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Abstract  
This study is to assess prospectively the performance of PCR in the diagnosis of Tuberculosis. The repetitive sequence 
IS6110 is used as a target for PCR. A total of five samples were analyzed all of which were found to be PCR positive. The 
results were compared with AFB staining, culture on Lowenstein Jensen (LJ) medium and Enzyme Linked Immunosorbant 
Assay (ELISA). PCR was found to be sensitive and specific and provides a definitive diagnosis of TB. Hence it is an effective 
tool for TB diagnosis. 
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INTRODUCTION 
On March 24th 1882, a german physician Robert Koch found 
that Tuberculosis, an infectious disease was caused by 
Mycobacterium tuberculosis. It is a disease of increasing importance. 
World Health Organization (WHO) has reported nearly three million 
deaths every year. In addition to this, there is an emergence of 
Multiple Drug Resistant (MDR) strains. Patients spread the disease 
by producing aerosols containing M.tuberculosis bacteria. Despite 
the availability of short term chemotherapy and the Bacilli-Calmette 
Guerin (BCG) vaccine, the tubercle bacilli continues to claim more 
lives than any other single infectious agent.1 The rapid development 
and availability of a variety of new molecular genetic technologies 
present the clinicians with an array of options for the accurate 
diagnosis of infectious diseases. Nucleic acid amplification methods 
to detect MTB in clinical samples are increasingly used as a tool of 
diagnosing TB.2 The emergence of PCR as a very powerful tool for 
the diagnosis of many infectious agents has been one of the 
momentous advances in the field of molecular biology.3 PCR based 
system have been useful for rapid detection of uncultivable or 
fastidious organisms. 
MATERIALS AND METHODS 
Clinical samples 
The clinical samples were collected from suspected patients 
from various hospitals and nursing homes of Thanjavur. These 
include body fluids like pleural fluid, Cerebro spinal fluid and Ascitic 
fluid. 
All the samples were stained for the presence of AFB by Ziehl-
Neelsen method and the cultures were inoculated on Lowenstein-
Jensen medium. Immunological examination of the samples was 
made by using the Dot ELISA kit for human IgG. 
Isolation of DNA 
Isolation of DNA from various body fluids was performed using 
the rapid and simple method adopted by Buch et al.4 1992 with minor 
modification4. 200 µl of lysis buffer (5.3 M Guanidine isothionate, 10 
mM Diethyribiol, 1% Tween 20, 0.3 M Sodium acetate, 50 mM 
Sodium citrate) and the mixture was incubated at 650C for 10 
minutes. 50 µl of glass mixing powder was added to the solution and 
incubated at room temperature with occasional shaking. Thereafter it 
was centrifuged at 10,000 rpm for 1 min. Supernatant was discarded 
and the matrix was resuspended in wash buffer (50 % Ethanol, 10 
mM Tris HCl, 100 mM Nacl). Bound DNA was eluted by periodic 
mixing in 10 µl of 10 mM Tris HCl. 
Primers used 
The primer sequences used for detection were 
 
 
The target for PCR was the insertion sequence IS6110. The 
primers yielded a 123 bp fragment with an internal Sal I site.5 IS6110 
has been said to be specific to MTB and most strains have between 
8-15 copies. 5, 6 & 7 
Amplification of DNA by PCR 
Primers, enzymes, buffers and other components needed to 
carry out the reaction were obtained from Bangalore Genei Ltd. 
Reaction mixture contained Taq polymerase, assay buffer, dNTP’s 
and primers with a total volume of 50 µl. Amplification was carried 
out on a thermal cycler (MJ-research) for about 35 cycles. The DNA 
was subjected to an initial denaturation at 940C for 3 mins. 
Primer Primer Sequence 
1 5’ CCT GCG AGC GTA GGC GTC GG 3’ 
2 5’ CTC GTC CAG CGC CGC TTC GG 3’ 
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Thereafter amplification was carried out at 900C for 1 min, 600C for 1 
min and 720C for 1 min. A final extension was carried out at 720C for 
5 mins. The amplification product i.e., the presence of 123 bp 
fragment was analyzed on 2 % agarose gel. 
Positive and Negative controls 
DNA extracted from MTB culture was used as a positive control. 
DNA extracted from normal patient was used as negative control.  
RESULTS 
In this study, the performance of PCR as a diagnostic tool for 
TB was assessed. A total of five samples were analysed. These 
include two samples of Ascitic fluid, two samples of Pleural fluid and 
one sample of CSF. DNA extracted from these samples was 
screened for the presence of 123 bp nucleotide sequence of IS6110, 
which is the target for PCR. All the five samples were found to be 
PCR positive when PCR products ran on gel with marker (Figure 1). 
The same samples were compared with other techniques namely, 
Microscopy, culture and ELISA. All the samples indicated smear 
negative and culture negative results. ELISA was found to be 
positive for all samples. But it is necessary to establish the presence 
of MTB DNA in all the five samples. Amplification of the repetitive 
sequence of MTB was found to contribute to the sensitivity of PCR. 
DISCUSSION 
Tuberculosis continues to be a global health problem despite 
the technical advancements made in detection, isolation and 
identification methods[8]. PCR has been acclaimed to be one of the 
sensitive tests for identifying the presence of an organism in question, 
in a clinical sample. PCR performed on five samples indicated the 
presence of MTB DNA in all the five samples. These five samples 
were found to be smear negative and culture negative as shown in 
table 1. Staining although rapid and inexpensive provides only a 
presumptive diagnosis of TB. A positive AFB smear result depends 
on the presence of atleast five thousand organisms/ml of the sample. 
Though it is straight forward, it does not allow differentiation between 
TB and non-TB bacteria[9]. Validity of this technique and sensitivity of 
this method is truly reflected in the analysis.
 
Table 1: Analysis of clinical samples 
S.No. Samples Staining Culture ELISA PCR 
1 Ascitic fluid 1 - - + + 
2 CSF - - + + 
3 Pleural fluid 1 - - + + 
4 Ascitic fluid 2 - - + + 
5 Pleural fluid 2 - - + + 





















Figure 1: Confirmation of IS6110 sequence on AGE 
 
 
On the other hand culture is still considered as a gold standard 
for TB diagnosis. It is able to detect as few as 10-100 bacteria/ml of 
digested concentrated material. In the case of TB-meningitis, it lacks 
sensitivity and positive results are obtained only in                
10-30 % of patients[10].  Further MTB can be isolated from CSF 
very rarely[11 & 12]. Both culture and smear which are found to be 
the definitive diagnosis for TB have failed to produce positive results. 
In a study, there was a report that pleural fluids from fifteen patients 
with tuberculous effusion was examined for MTB DNA by PCR 
technique were found to be positive while none were positive in 
smears and only three samples were positive in culture[8]. 
However, in the ELISA test all the five samples produced a 
positive result, thus indicating infection. Presence of IgG in the fluids 
indicate an infection either recent or remote[13]. However isolation of 
MTB is imperative for definitive diagnosis of tuberculosis[14]. The 
problem of false positivity of PCR was neglected because the 
presence of infection was confirmed by the ELISA test, though the 
samples were culture and smear negative. 
The detection of MTB by PCR in smear negative and culture 
negative cases assumes a lot of clinical significance, because such 
as these cases in the absence of a technique like PCR would have 
to be assumed to be tuberculosis and treated empirically or lose the 
benefit of life saving therapy if bacteriologic proof is insisted upon[15]. 
PCR has been shown to be sensitive (88-100%)[16 & 17] and 
specific (> 90 %). Various authors have shown the sensitivity of 
PCR[18 & 19]. High sensitivity of PCR is due to the repetitive nature 
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of the target sequence amplified by PCR, suggesting that the assay 
is more sensitive than smear/culture in detecting non viable or fewer 
viable organisms[20].     
In conclusion, it was suggested that early diagnosis is as crucial 
as treatment and prevention for the control of Tuberculosis. PCR can 
be used as a rapid, sensitive, specific and reliable tool for the 
diagnosis of TB, especially in cases where it is difficult to identify the 
bacteria by conventional methods. Thus it provides a bacteriological 
diagnosis. As per this study, it provides extraordinary results in 
extrapulmonary tuberculosis. 
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